Silver Book Fact

In a community-based pharmaceutical care services program for 194 participants in 2001, mean A1c decreased at follow-ups, with more than 50% of patients demonstrating improvements at each interval (each year for 1-5 years).

Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen. The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc. 2003; 43(2): 173-84. http://www.ncbi.nlm.nih.gov/pubmed/12688435

Reference

Title
The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program
Publication
J Am Pharm Assoc
Publication Date
2003
Authors
Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen
Volume & Issue
Volume 43, Issue 2
Pages
173-84
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Every additional dollar spent on statin therapy for diabetes patients without cardiovascular disease has produced health gains valued between $7 and $31.  
  • Widespread use of diabetes prevention drugs that enhance insulin sensitivity could result in a 50% prevention of type 2 diabetes over a 10 to 15 year period.  
  • For every 10 mmHg reduction in systolic blood pressure, the risk of diabetic complications is reduced by 12%.  
  • A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members…  
  • Medicines Reduce Complications of Diabetes: Diabetes patients treated with medicines are less likely to develop other health problems